by jlohrconsulting | Oct 28, 2025 | Uncategorized
Neuropsychiatr Dis Treat. 2025 Oct 22;21:2371-2384. doi: 10.2147/NDT.S527763. eCollection 2025. ABSTRACT BACKGROUND AND OBJECTIVE: Subclinical depression and lower urinary tract symptoms (LUTS) /benign prostatic hyperplasia (BPH) are both common diseases. Studies have...
by jlohrconsulting | Oct 28, 2025 | Uncategorized
Int J Clin Health Psychol. 2025 Oct-Dec;25(4):100640. doi: 10.1016/j.ijchp.2025.100640. Epub 2025 Oct 17. ABSTRACT INTRODUCTION: Depression is common among cancer patients, adversely affecting treatment adherence, toxicity, and quality of life (QoL). However, its...
by jlohrconsulting | Oct 28, 2025 | Uncategorized
PCN Rep. 2025 Oct 26;4(4):e70232. doi: 10.1002/pcn5.70232. eCollection 2025 Dec. ABSTRACT AIM: Demoralization, which is characterized by helplessness, hopelessness, and the loss of meaning, has gained increasing attention in psychiatry and palliative care. Robinson et...
by jlohrconsulting | Oct 28, 2025 | Uncategorized
PCN Rep. 2025 Oct 26;4(4):e70231. doi: 10.1002/pcn5.70231. eCollection 2025 Dec. NO ABSTRACT PMID:41146987 | PMC:PMC12554321 | DOI:10.1002/pcn5.70231
by jlohrconsulting | Oct 28, 2025 | Uncategorized
Int J Methods Psychiatr Res. 2025 Dec;34(4):e70041. doi: 10.1002/mpr.70041. ABSTRACT OBJECTIVES: Plasma phosphoethanolamine (PEA) has been proposed as a potential biomarker for depressive disorder. To further assess its diagnostic utility and relevance across...
Recent Comments